Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Ramipril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Ramipril. |
| Fosinopril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Fosinopril. |
| Trandolapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Trandolapril. |
| Benazepril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Benazepril. |
| Enalapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Enalapril. |
| Moexipril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Moexipril. |
| Lisinopril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Lisinopril. |
| Perindopril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Perindopril. |
| Quinapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Quinapril. |
| Omapatrilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Omapatrilat. |
| Rescinnamine | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Rescinnamine. |
| Captopril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Captopril. |
| Cilazapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Cilazapril. |
| Spirapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Spirapril. |
| Temocapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Temocapril. |
| Enalaprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Enalaprilat. |
| Imidapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Imidapril. |
| Zofenopril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Zofenopril. |
| Delapril | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Delapril. |
| Benazeprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Benazeprilat. |
| Fosinoprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Fosinoprilat. |
| Ramiprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Ramiprilat. |
| Trandolaprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Trandolaprilat. |
| Moexiprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Moexiprilat. |
| Perindoprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Perindoprilat. |
| Quinaprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Quinaprilat. |
| Cilazaprilat | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Cilazaprilat. |
| Triamterene | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Triamterene. |
| Spironolactone | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Spironolactone. |
| Amiloride | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Amiloride. |
| Eplerenone | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Eplerenone. |
| Canrenoic acid | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Canrenoic acid. |
| Canrenone | The risk or severity of hyperkalemia can be increased when Potassium acetate is combined with Canrenone. |
| Cefotiam | Cefotiam may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefmenoxime | Cefmenoxime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefmetazole | Cefmetazole may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Pamidronic acid | Pamidronic acid may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Tenofovir disoproxil | Tenofovir disoproxil may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cidofovir | Cidofovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefpiramide | Cefpiramide may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftazidime | Ceftazidime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Loracarbef | Loracarbef may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefalotin | Cefalotin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefotaxime | Cefotaxime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Foscarnet | Foscarnet may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Methotrexate | Methotrexate may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cephalexin | Cephalexin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Valaciclovir | Valaciclovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Bacitracin | Bacitracin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Amphotericin B | Amphotericin B may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cephaloglycin | Cephaloglycin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Adefovir dipivoxil | Adefovir dipivoxil may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Acyclovir | Acyclovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefaclor | Cefaclor may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceforanide | Ceforanide may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Carboplatin | Carboplatin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefditoren | Cefditoren may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Atazanavir | Atazanavir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Colistimethate | Colistimethate may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefuroxime | Cefuroxime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefapirin | Cefapirin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefadroxil | Cefadroxil may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefprozil | Cefprozil may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftriaxone | Ceftriaxone may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefamandole | Cefamandole may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefazolin | Cefazolin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefonicid | Cefonicid may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefoperazone | Cefoperazone may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefotetan | Cefotetan may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefoxitin | Cefoxitin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftizoxime | Ceftizoxime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefradine | Cefradine may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefepime | Cefepime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefacetrile | Cefacetrile may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftibuten | Ceftibuten may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefpodoxime | Cefpodoxime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Lopinavir | Lopinavir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Hydrolyzed Cephalothin | Hydrolyzed Cephalothin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cephalothin Group | Cephalothin Group may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Latamoxef | Latamoxef may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftobiprole | Ceftobiprole may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftaroline fosamil | Ceftaroline fosamil may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefaloridine | Cefaloridine may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefminox | Cefminox may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Tenofovir alafenamide | The serum concentration of Tenofovir alafenamide can be increased when it is combined with Potassium acetate. |
| Cefroxadine | Cefroxadine may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Flomoxef | Flomoxef may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefatrizine | Cefatrizine may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefcapene | Cefcapene may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefodizime | Cefodizime may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefsulodin | Cefsulodin may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefetamet | Cefetamet may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefbuperazone | Cefbuperazone may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefozopran | Cefozopran may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefpirome | Cefpirome may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Cefazedone | Cefazedone may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Ceftezole | Ceftezole may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Adefovir | Adefovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Tenofovir | Tenofovir may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |
| Inotersen | Inotersen may decrease the excretion rate of Potassium acetate which could result in a higher serum level. |